MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2023-24)
- Udyam number
- UDYAM-UP-29-0015827
SGS Pharmaceutical Pvt Ltd - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹58.96 Cr
▲ 37% YoY
Net profit · FY 2024
₹1.52 Cr
Net margin 2.6%
EBITDA · FY 2024
₹2.78 Cr
EBITDA margin 4.7%
Authorised capital
₹1.75 Cr
Registered with MCA
Paid-up capital
₹1.3 Cr
Issued & subscribed
Open charges
₹15.22 Cr
Secured borrowings
Company age
25 yrs
Est. 2001
Employees · EPFO
62
Provident fund records
About SGS Pharmaceutical Pvt Ltd
Data last updated:
SGS Pharmaceutical Pvt Ltd is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 08 May 2001 and has been in existence for over 25 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24239DL2001PTC110738. Its GSTIN is 05AAGCS7547F2Z7 (Uttarakhand). The company holds 3 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹1.75 Cr and a paid-up capital of ₹1.3 Cr. It is led by directors Nimish Gupta and Manvendra Singh.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 1608 Dewan Hall Building6/2 Ist Floor Bhagirathi Place, New Delhi, Delhi, India – 110006.
As per the financials filed for FY 2024, the company reported a revenue of ₹58.96 Cr, a growth of 37% compared to the previous year. For the same year it recorded a net profit of ₹1.52 Cr (net margin 2.6%) and EBITDA of ₹2.78 Cr (EBITDA margin 4.7%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years and 7% over five years.
The company has about 62 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: SGS Pharmaceuticals. As per MCA filings, the company has open charges of ₹15.22 Cr on record. Court records list 18 cases involving the company, including 4 filed by the company and 14 filed against it; 4 cases are pending. The company has 6 deals on record (3 funding rounds, 3 secondary share transfers), with disclosed funding of ₹1.99 Cr; the latest was in December 2022. Its 4 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 1 smaller; the largest is Deccan Health Care Limited with revenue of ₹59.74 Cr.
SGS Pharmaceutical Pvt Ltd is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-29-0015827). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sgspharma.com.
Company details
CIN U24239DL2001PTC110738
Registration Number 110738
Incorporation Date 08 May 2001
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-UP-29-0015827
Key People
Nimish Gupta Director Manvendra Singh Director Recognitions & Rankings of SGS Pharmaceutical
Contact details
SGS Pharmaceutical Pvt Ltd's registered office is in New Delhi, Delhi. Its website is sgspharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address1608 Dewan Hall Building6/2 Ist Floor Bhagirathi Place, New Delhi, Delhi, India – 110006
- IndustryPharma, Drug Formulation & Development
To see the full contact details of SGS Pharmaceutical Pvt Ltd, buy the company report.
Comprehensive company report
SGS Pharmaceutical Pvt Ltd - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
SGS Pharmaceutical operates one associated brand: SGS Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures high-quality pharmaceutical products such as tablets, capsules, syrups, semi-solids, and injectables. | sgspharma.com |
Business activity
The main business activity of SGS Pharmaceutical is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of SGS Pharmaceutical Pvt Ltd, buy the company report.
Financials of SGS Pharmaceutical Pvt Ltd
FY 2024 filings availableSGS Pharmaceutical Pvt Ltd reported revenue of ₹58.96 Cr (up 37% YoY) for FY 2024.
Revenue · FY 2024
₹58.96 Cr ▲ 37%
Net profit · FY 2024
₹1.52 Cr margin 2.6%
EBITDA · FY 2024
₹2.78 Cr margin 4.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 37%
3 years · compounded
▼ 6%
5 years · compounded
▲ 7%
EBITDA CAGR growth
1 year
▲ 35%
3 years · compounded
▲ 11%
5 years · compounded
▲ 17%
Revenue has grown at a compounded annual rate (CAGR) of 7% over five years, including 37% growth in the latest year. EBITDA rose 35% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.78 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.52 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.7% | ||||
| Net Profit Margin | 2.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of SGS Pharmaceutical Pvt Ltd, buy the company report.
Board of directors of SGS Pharmaceutical Pvt Ltd
SGS Pharmaceutical has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nimish Gupta | Director | 20 Feb 2007 | 19 Years 8 Months | Current |
| Manvendra Singh | Director | 30 Jan 2019 | 7 Years 9 Months | Current |
Peer comparison
SGS Pharmaceutical Pvt Ltd is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Deccan Health Care Limited | ₹59.74 Cr (FY 2024) | 33.0% | Hyderabad, Telangana, India | |||
| Systole Remedies Private Limited | ₹59.68 Cr (FY 2025) | 28.0% | Delhi, India | |||
| Vega Biotec Private Limited | ₹59.17 Cr (FY 2025) | 38.0% | Vadodara, Gujarat, India | |||
| SGS Pharmaceutical Pvt Ltdthis company | ₹58.96 Cr (FY 2024) | ₹1.52 Cr | 2.6% | 37.0% | 62 | New Delhi, Delhi, India |
| Ocean Healthcare Private Limited | ₹58.49 Cr (FY 2025) | -8.0% | Egmore Nungambakkm, Tamil Nadu, India |
To see the full peer comparison of SGS Pharmaceutical Pvt Ltd, buy the company report.
Auditor
SGS Pharmaceutical Pvt Ltd is audited by SANDEEP KAPOOR & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SANDEEP KAPOOR & CO. | FY 2023 | 010288C |
Shareholding
The shareholding of SGS Pharmaceutical Pvt Ltd is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of SGS Pharmaceutical Pvt Ltd, buy the company report.
Charges & borrowings
Open charges
₹15.22 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 29 Oct 2020 | 100418251 | Hdfc Bank Limited | ₹35 Lakh | Open | |
| 04 Jan 2006 | 80061610 | State Bank of India | ₹10.51 Cr | Open | |
| 04 Jan 2006 | 90331256 | State Bank of India | ₹3.36 Cr | Open | |
| 04 Jan 2006 | 80061609 | State Bank of India | ₹1 Cr | Open |
To see the full charge records of SGS Pharmaceutical Pvt Ltd, buy the company report.
Total charge records: 4 View all charges
Deals & funding
SGS Pharmaceutical Pvt Ltd has 6 deals on record (3 funding rounds, 3 secondary share transfers), with disclosed funding of ₹1.99 Cr; the latest was in December 2022.
Total deals
6
Funding rounds
3
Secondary share transfers
3
Disclosed funding
₹1.99 Cr
Deals on record (5 of 6)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Dec 2022 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: Omega Biotech Limited |
| Feb 2022 | Funding round | ₹32.7 Lakh | Investors: 2 individuals |
| Apr 2019 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Nikhil Builders and Promoters Private Limited , Shri Dinanath Luhariwala Spinning Mills Private Limited, Kesri Industrial Lab Private Limited |
| May 2015 | Funding round | ₹67.1 Lakh | Investors: 2 individuals |
| Oct 2010 | Funding round | ₹99 Lakh | Investors: Omega Biotech Limited , 3 individuals |
To see the full deal history of SGS Pharmaceutical Pvt Ltd, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
SGS Pharmaceutical Pvt Ltd has 18 court cases on record: 4 filed by SGS Pharmaceutical, 14 filed against it. 4 cases are pending and 14 are disposed.
Total cases
18
Filed by the company
4
Filed against the company
14
Pending
4
Disposed
14
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 11 | 7 | 1 |
| District courts | 7 | 7 | 3 |
Cases on record (5 of 18)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, MAHARASHTRA | Court case (CRR) | Filed against the company by Procter and Gamble Hygiene and Health Care Limited and Anr | Pending |
| High Court of Delhi | Commercial suit | Filed against the company by Sanofi Consumer Healthcare India Limited | Disposed |
| High Court of Delhi | Commercial suit | Filed against the company by Alkem Laboratories Ltd. | Disposed |
| High Court, UTTARAKHAND | Arbitration matter | Filed by the company against Rajasthan Medical Service Corporation Ltd. | Disposed |
| High Court, UTTARAKHAND | Court case (WPMS) | Filed by the company against Rajasthan Medical Service Corporation Ltd and 3 others | Disposed |
To see the full case history of SGS Pharmaceutical Pvt Ltd, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for SGS Pharmaceutical Pvt Ltd; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
SGS Pharmaceutical Pvt Ltd has a workforce of 62 employees on its EPFO records as of Mar 26, 2025, across 2 active EPFO establishments.
Employee count
62
Active EPFO establishments
2
Employee growth
10.71%
GST
SGS Pharmaceutical has 3 GST registrations: 2 active and 1 cancelled or inactive.
Total GSTINs
3
Active
2
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AAGCS7547F2Z7 | Uttarakhand | Active | 01 Jul 2017 |
| 09AAGCS7547F1Z0 | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of SGS Pharmaceutical Pvt Ltd, buy the company report.
Recent activity
SGS Pharmaceutical Pvt Ltd has 6 board changes on record since 2007: 2 appointments and 4 cessations. The latest: Manvendra Singh ceased to be Additional Director on 30 Sep 2019.
AGM
Sgs Pharmaceutical Pvt Ltd last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Sgs Pharmaceutical Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Charges
A charge with State Bank Of India of Rs. 10.51 Cr registered on 04 Jan 2006 with Charge ID 80061610 was modified on 10 Jul 2023.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.35 Cr with Charge ID 100418251 was registered on 29 Oct 2020.
Ceased
Manvendra Singh ceased to be Additional Director.
Ceased
Pramod Kumar ceased to be Additional Director.
Ceased
Vipin Gupta ceased to be Director.
Appointed
Manvendra Singh was appointed as Director.
Ceased
Anita Gupta ceased to be Director.
Charges
A charge with State Bank Of India of Rs. 3.36 Cr registered on 04 Jan 2006 with Charge ID 90331256 was modified on 29 Nov 2010.
Appointed
Nimish Gupta was appointed as Director.
Charges
A charge with State Bank Of India amounted to Rs. 1.00 Cr with Charge ID 80061609 was registered on 04 Jan 2006.
3 earlier events are in the company report.
Frequently asked questions
SGS Pharmaceutical is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 08 May 2001 (25+ years old) and is registered under CIN U24239DL2001PTC110738.
SGS Pharmaceutical has 2 current directors:
- Nimish Gupta - Director
- Manvendra Singh - Director
The latest financial statements of SGS Pharmaceutical on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of SGS Pharmaceutical is 05AAGCS7547F2Z7, registered in Uttarakhand. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 09AAGCS7547F1Z0 (Uttar Pradesh).
The CIN (Corporate Identification Number) of SGS Pharmaceutical is U24239DL2001PTC110738. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
SGS Pharmaceutical has 18 court cases on record: 4 filed by the company and 14 filed against it. 4 are pending. Most are in the high courts.
SGS Pharmaceutical was incorporated on 08 May 2001, making it 25+ years old. It is registered with the Registrar of Companies, Delhi.
SGS Pharmaceutical has 6 deals on record (3 funding rounds, 3 secondary share transfers), with disclosed funding of ₹1.99 Cr; the latest was in December 2022.
The peers of SGS Pharmaceutical by revenue are Deccan Health Care Limited, Systole Remedies Private Limited, Vega Biotec Private Limited, Ocean Healthcare Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Manvendra Singh ceased to be Additional Director on 30 Sep 2019. Pramod Kumar ceased to be Additional Director on 30 Sep 2019. Vipin Gupta ceased to be Director on 21 Feb 2019. SGS Pharmaceutical has 6 board changes on record in total.
Yes, SGS Pharmaceutical is registered as a medium enterprise under Udyam registration (number: UDYAM-UP-29-0015827).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages